Praxis Precision Medicines, Inc.
PRAX
Jodie situation report
Praxis Precision Medicines, Inc.'s move is being confirmed by its market group.
PRAX accounts for 12.7% of the group's measured movement across 5.6 effective names. raw member direction is mixed; 7 of 12 session-normalized paths align to the upside. Capital-flow agreement is 16%, so confirmation is not yet clean. No verified headline preceded the measured group move.
Is this move genuinely shared?
AXSM, ALMS, GPCR moved materially before PRAX. PRAX crossed its material path threshold at 15:05 ET, 1395 minutes after the first measured mover. RCUS, MAZE, TYRA followed.
- The operating loss widened by 20.8M.
10 of 16 members in Clinical Biopharmaceuticals are active. 0 of 3 disclosed connections are confirming.
- At least 11 of 16 durable members become active together.
- Capital-flow agreement rises above 55%.
- A filing-linked outsider such as NBIX begins moving with the group.
Invalidation: The live read weakens if participation falls to 5 of 16 members or fewer.
Who this business touches
The relationships behind PRAX
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 3 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
PRAX is currently a Participant in the organic co-movement group Clinical Biopharmaceuticals. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.